Pseudomonas aeruginosa - a phenomenon of bacterial resistance.

By T. Strateva, D. Yordanov. Journal of Medical Microbiology, 2009

874 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Pseudomonas aeruginosa: new insights into pathogenesis and host defenses. (2013, background): “The resistance imparted by efflux pumps and AmpC is intricately connected to restricted outer membrane permeability, because the concentration of b-lactams in the periplasm is dependent on the efficiency and rate by which they are transported through the porins of the outer membrane (Jacoby, 2009).”
How to manage Pseudomonas aeruginosa infections (2018, background): “aeruginosa including PER, VEB, GES and BEL types [23].”
Action and resistance mechanisms of antibiotics: A guide for clinicians (2017, background): “These aminoglycoside-modifying enzymes (AMEs) reduce affinity of a modified molecule, impede binding to the 30S ribosomal subunit,[28] and provide extended spectrum resistance to AG’s and FQ.”
Pseudomonas Aeruginosa: Resistance to the Max (2011, background): “aeruginosa (Strateva and Yordanov, 2009), more commonly mutations of chromosomal genes (target site, efflux mutations) explain resistance in this organism (Lister et al., 2009; Strateva and Yordanov, 2009).”